Literature DB >> 6230279

Course, prognosis and complications of childhood-onset myotonic dystrophy.

T A O'Brien, P S Harper.   

Abstract

The outcome for 71 patients with childhood-onset myotonic dystrophy was examined. In addition to 18 patients with later onset, but presenting in childhood, and 46 with the congenital form, seven patients from congenital sibships who did not present in the neonatal period were found to have myotonic dystrophy of intermediate severity. The incidence of the congenital form in South Wales was six per 100,000. In all groups the mortality rate was low after the perinatal period. The prognosis for normal family life and ultimate gainful employment was poor. Testicular atrophy in congenitally affected males was evident at puberty, and there was a high incidence of gastro-intestinal problems. The contributions of deafness as a result of recurrent otitis, and of severe articulation defects, should be considered when assessing the degree of mental handicap.

Entities:  

Mesh:

Year:  1984        PMID: 6230279     DOI: 10.1111/j.1469-8749.1984.tb04407.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  11 in total

1.  Progressive atrioventricular conduction block in a mouse myotonic dystrophy model.

Authors:  C I Berul; C T Maguire; J Gehrmann; S Reddy
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

2.  Genetic risks for children of women with myotonic dystrophy.

Authors:  M C Koch; T Grimm; H G Harley; P S Harper
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

3.  Towards an integrative approach to the management of myotonic dystrophy type 1.

Authors:  Cynthia Gagnon; Luc Noreau; Richard T Moxley; Luc Laberge; Stéphane Jean; Louis Richer; Michel Perron; Suzanne Veillette; Jean Mathieu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-20       Impact factor: 10.154

4.  Knowledge, views, and experience of 25 women with myotonic dystrophy.

Authors:  C L Faulkner; H M Kingston
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

5.  Cardiac involvement in congenital myotonic dystrophy.

Authors:  H Forsberg; B O Olofsson; A Eriksson; S Andersson
Journal:  Br Heart J       Date:  1990-02

6.  Paternal transmission of congenital myotonic dystrophy.

Authors:  C E de Die-Smulders; H J Smeets; W Loots; H B Anten; J F Mirandolle; J P Geraedts; C J Höweler
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

7.  DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model.

Authors:  C I Berul; C T Maguire; M J Aronovitz; J Greenwood; C Miller; J Gehrmann; D Housman; M E Mendelsohn; S Reddy
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

8.  The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects.

Authors:  W Reardon; R Newcombe; I Fenton; J Sibert; P S Harper
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

Review 9.  Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.

Authors:  Genevieve Ho; Michael Cardamone; Michelle Farrar
Journal:  World J Clin Pediatr       Date:  2015-11-08

10.  Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1).

Authors:  Jordan T Gladman; Mahua Mandal; Varadamurthy Srinivasan; Mani S Mahadevan
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.